Rockefeller Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.5M | Buy |
700,668
+23,234
| +3% | +$1.35M | 0.08% | 253 |
|
|
2025
Q4 | $36.5M | Sell |
677,434
-83,849
| -11% | -$4.03M | 0.07% | 287 |
|
|
2025
Q3 | $34.3M | Buy |
761,283
+38,569
| +5% | +$1.8M | 0.07% | 267 |
|
|
2025
Q2 | $33.5M | Buy |
722,714
+171,913
| +31% | +$8.44M | 0.07% | 250 |
|
|
2025
Q1 | $33.6M | Buy |
550,801
+7,081
| +1% | +$413K | 0.08% | 235 |
|
|
2024
Q4 | $30.7M | Sell |
543,720
-372,520
| -41% | -$20.8M | 0.08% | 242 |
|
|
2024
Q3 | $47.4M | Sell |
916,240
-10,785
| -1% | -$506K | 0.13% | 167 |
|
|
2024
Q2 | $38.5M | Buy |
927,025
+90,101
| +11% | +$4.03M | 0.11% | 181 |
|
|
2024
Q1 | $45.4M | Buy |
836,924
+244,951
| +41% | +$12.5M | 0.13% | 160 |
|
|
2023
Q4 | $30.4M | Sell |
591,973
-198,652
| -25% | -$10.4M | 0.1% | 208 |
|
|
2023
Q3 | $45.9M | Sell |
790,625
-157,003
| -17% | -$9.62M | 0.18% | 134 |
|
|
2023
Q2 | $59.4M | Buy |
947,628
+36,294
| +4% | +$2.43M | 0.23% | 102 |
|
|
2023
Q1 | $63.2M | Buy |
911,334
+187,528
| +26% | +$13.2M | 0.27% | 89 |
|
|
2022
Q4 | $52.1M | Sell |
723,806
-25,228
| -3% | -$1.9M | 0.26% | 98 |
|
|
2022
Q3 | $53.2M | Buy |
749,034
+99,931
| +15% | +$7.25M | 0.28% | 84 |
|
|
2022
Q2 | $50M | Sell |
649,103
-61,714
| -9% | -$4.7M | 0.27% | 85 |
|
|
2022
Q1 | $51.9M | Buy |
710,817
+16,774
| +2% | +$1.13M | 0.25% | 96 |
|
|
2021
Q4 | $43.3M | Sell |
694,043
-199,316
| -22% | -$11.7M | 0.2% | 121 |
|
|
2021
Q3 | $52.9M | Buy |
893,359
+56,007
| +7% | +$3.69M | 0.28% | 78 |
|
|
2021
Q2 | $56M | Buy |
837,352
+234,152
| +39% | +$15.3M | 0.32% | 70 |
|
|
2021
Q1 | $38.1M | Buy |
603,200
+43,468
| +8% | +$2.7M | 0.26% | 91 |
|
|
2020
Q4 | $34.7M | Buy |
559,732
+46,468
| +9% | +$2.86M | 0.26% | 93 |
|
|
2020
Q3 | $30.9M | Buy |
513,264
+56,597
| +12% | +$3.41M | 0.29% | 84 |
|
|
2020
Q2 | $26.9M | Buy |
456,667
+5,355
| +1% | +$320K | 0.28% | 79 |
|
|
2020
Q1 | $25.2M | Buy |
451,312
+204,413
| +83% | +$12.5M | 0.33% | 64 |
|
|
2019
Q4 | $15.8M | Buy |
246,899
+58,990
| +31% | +$3.38M | 0.2% | 110 |
|
|
2019
Q3 | $9.53M | Buy |
187,909
+88,067
| +88% | +$4.14M | 0.13% | 142 |
|
|
2019
Q2 | $4.53M | Sell |
99,842
-107,736
| -52% | -$5.02M | 0.06% | 171 |
|
|
2019
Q1 | $9.9M | Buy |
207,578
+10,337
| +5% | +$515K | 0.14% | 120 |
|
|
2018
Q4 | $10.3M | Buy |
197,241
+58,786
| +42% | +$3.16M | 0.18% | 106 |
|
|
2018
Q3 | $8.6M | Sell |
138,455
-6,650
| -5% | -$395K | 0.13% | 112 |
|
|
2018
Q2 | $8.03M | Sell |
145,105
-202,521
| -58% | -$10.9M | 0.13% | 112 |
|
|
2018
Q1 | $22M | Buy |
+347,626
| New | +$22.4M | 0.36% | 74 |
|
Other funds holding BMY
VCM
VPM
Rockefeller Capital Management's BMY Position: Q1 2026 in Review
Rockefeller Capital Management increased its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, buying an estimated $1.35M and bringing the position to 700,668 shares worth $42.5M. The position accounts for 0.08% of the portfolio, ranked #253.
Rockefeller Capital Management first reported a position in BMY in Q1 2018 and has held it in 33 quarters since. The position peaked at $63.2M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Rockefeller Capital Management held 700,668 shares of Bristol-Myers Squibb worth $42.5M as of Q1 2026.
- Rockefeller Capital Management bought 23,234 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.35M.
- Bristol-Myers Squibb made up 0.08% of Rockefeller Capital Management's portfolio in Q1 2026, its #253 holding.
- Rockefeller Capital Management first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's Bristol-Myers Squibb position peaked at $63.2M in Q1 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.